Assessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)

Authors :: Robin Katie Kelley
Suvajit Sen
Debashis Sarker
Benjamin R. Tan
A-L Cheng
E. Banu
C. Love
Baek-Yeol Ryoo
H. Van Vlierberghe
Ghassan K. Abou-Alfa
Tim Meyer
Irfan Cicin
William P. Harris
Thomas Yau
Lorenza Rimassa
Philippe Merle
Source :: Annals of Oncology. 29:ix46
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Full Text Access

Tools